Early-Stage Development of Informatics Technologies for Cancer Research and Management (U01 Clinical Trial Optional)
Issued by National Institutes of Health · via Grants.gov — US federal funding opportunities
- Published
- 21 May 2026
- Closes
- 19 Oct 2027, 23:59 UTC
- Value
- USD 2,400,000
- Reference
- RFA-CA-27-019
- Location
- United States
- Sector
- Healthcare & Pharma
At a glance
National Institutes of Health in United States has published a funding call in healthcare & pharma: “Early-Stage Development of Informatics Technologies for Cancer Research and Management (U01 Clinical Trial Optional)”. Submissions close on 19 October 2027, 341 days from today. The stated value is USD 2,400,000. Quote reference RFA-CA-27-019 in any correspondence with the buyer. FreeTender has recorded 459 notices from this buyer since 2023, 372 of them currently open. There are 395 open healthcare & pharma notices in United States on FreeTender. Bids are submitted to the buyer through Grants.gov — US federal funding opportunities, not through FreeTender.
Key requirements
Taken from the notice by FreeTender. The tender document on the official portal is binding — check it, and any corrigendum, before you bid.
To bid on Grants.gov (US federal)
Applicants need a UEI from SAM.gov and a Grants.gov account registered to their organisation; allow several weeks for registration.
Details
This Notice of Funding Opportunity (NOFO) solicits applications for the development of enabling informatics technologies to improve the acquisition, management, analysis, and dissemination of data and knowledge across the cancer research continuum including cancer biology, cancer treatment and diagnosis, early cancer detection, risk assessment and prevention, cancer control and epidemiology. As a component of the NCI's Informatics Technology for Cancer Research (ITCR) Program, this NOFO is focused on early-stage development from prototyping to initial dissemination. Early-stage development is defined for the purpose of this NOFO as initial tool development or the significant modification of existing tools for new applications. The central mission of ITCR is to promote research-driven informatics technology across the development lifecycle to address priority needs in cancer research. In order to be successful, proposed development plans must have a clear rationale for why the proposed technology is needed and how it will benefit the cancer research field. In addition, mechanisms to solicit feedback from driving research projects and other users throughout the development process must be included.This NOFO encourages applications that involve the development of new, user-friendly informatics technologies that support a wide range of cancer research, including discovery biology, population studies, as well as clinical and translational research. The emphasis is on uniqueness and potential impact on cancer research. In addition, all projects proposed in response to this NOFO must involve the following general attributes:Potential to advance driving cancer research projects and the cancer research field in generalNovel informatics capabilities for the targeted cancer research domainCompelling plans and processes for engaging end users to evaluate and apply the tool or resourceA realistic timeline and milestones for technology development Eligibility: Refer to Section III. Eligibility Information in the NOFO for additional information on eligibility.Foreign Organizations/International Collaborations:Non-domestic (non-U.S.) Entities (Foreign Organizations) are eligible to apply.Non-domestic (non-U.S.) components of U.S. Organizations are eligible to apply.Foreign components, as defined in the NIH Grants Policy Statement, are allowed.
Estimated total programme funding: USD 2400000
Award range: USD 50000 – 300000
Expected number of awards: 5
CFDA number(s): 93.393
Federal funding opportunity published on Grants.gov. Applications are submitted through Grants.gov — see the official listing.
Context for bidders
We hold 459 notices from National Institutes of Health, going back to May 2023 — 372 of them still open. They buy mostly in Healthcare & Pharma, Education & Training and Water & Environment. There are 395 open Healthcare & Pharma tenders in United States. This one closes in 341 days.
More from this buyer
- Advancing Real-World Effectiveness Evidence for Rapid-Acting Psychotropic Interventional Drugs (RAPIDs) (UM1 Clinical Trial Required)· closes 10 Jun
- NCI Research Specialist (Clinician Scientist) Award (R50 Clinical Trial Not Allowed)· closes 20 Feb
- Genomic and Biologic Therapies for ADRD (U01 Clinical Trial Optional)· closes 10 Oct
- The NIDDK Disorders of Gastrointestinal Interoception Consortium (DGIC) Scientific Data Research Center (U24 Clinical Trial Not Allowed)· closes 5 Mar
- George M. O’Brien Urology Cooperative Research Centers Program (U54 Clinical Trial Optional)· closes 1 Feb
Similar Healthcare & Pharma tenders
- Research Grants Supporting Scientific Discovery, Academic Research and New Studies· closes 18 Jan
- Litter, Folding, Pole — 67 each, NSN 6530016631222· closes 18 Nov
- Blanket, Heating — 375 packages, NSN 6532015254062· closes 17 Nov
- Apply now for Episcopal Health Foundation Cycle 1 Grant (United States)· closes 30 Nov
- Advancing Real-World Effectiveness Evidence for Rapid-Acting Psychotropic Interventional Drugs (RAPIDs) (UM1 Clinical Trial Required)· closes 10 Jun
Before you bid on this tender
A quick checklist to help you decide whether to bid and prepare a compliant submission for this healthcare & pharma opportunity. Always verify the details on the official source.
- Confirm the exact closing date and time (and time zone) on the official portal — deadlines are strict and can be revised by a corrigendum.
- Read the full notice and every attached document, including the scope, specifications and any bill of quantities or terms of reference.
- Check the eligibility criteria — prior similar experience, annual turnover, certifications and registrations — and make sure you qualify before investing effort.
- Prepare any earnest-money deposit (EMD) or bid security and the required formats early; missing or wrongly-formatted documents are a common cause of rejection.
- Note how bids must be submitted (online or physical), in what format, and whether a digital signature or portal registration is required.
- Watch for corrigenda and clarifications right up to the deadline — requirements and dates can change.
More Healthcare & Pharma tenders
- Поставка медицинских масокГУЗ "СГКБ № 6 имени академика В.Н.Кошелева" · Russia
- Поставка медицинского оборудования (Термометр бесконтактный, весы медицинские напольные, пульсоксиметр на палец)ГОСУДАРСТВЕННОЕ АВТОНОМНОЕ УЧРЕЖДЕНИЕ ЗДРАВООХРАНЕНИЯ "ЭНГЕЛЬССКАЯ ГОРОДСКАЯ КЛИНИЧЕСКАЯ БОЛЬНИЦА № 1" · Russia
- Поставка медицинских изделий (шприцы)ГБУЗ "ВОККВД" · Russia
- Оказание платных медицинских услуг (патологоанатомические исследования на 2027 год)ГОСУДАРСТВЕННОЕ БЮДЖЕТНОЕ УЧРЕЖДЕНИЕ ЗДРАВООХРАНЕНИЯ "ГОРОДСКАЯ КЛИНИЧЕСКАЯ БОЛЬНИЦА № 3" · Russia
- Поставка косметических средств (защитные патчи Эпилайк)ГБУЗ "ВОККВД" · Russia
FreeTender mirrors this notice for reference. Verify the details and bid on the official portal.
Verify & apply on the official portal →